Q122 SCS Market revenues were up in the low-single digit YoY, but pandemic-related issues made it a bumpy ride
Among the many topics covered in detail in our comprehensive Q122 Spinal Cord Stimulation Market Recap* are:
- Complete Q122 Spinal Cord Stimulation Market Overview
- SmartTRAK's Expert Analysis and Insights
- All Market News including Revenues, Data, Charts and Shares
- Top Competitor Results & Highlights
- Important Q122 SCS News and Events
A surge in Omicron cases late in Q421 continued into January Q122 before dropping again in February, impacting revenues for some competitors more than others depending on ...
*The entire unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below. 
SmartTRAK is the leading source of competitive intelligence used by the top ten global wound care & orthopedics companies. If you would like a demo of what SmartTRAK has to offer and how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
